| Date Filed | Type | Description |
| 08/10/2023 |
4
| Abdun-Nabi Daniel (Director) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Exercised 3,571 restricted stock units
@ $0 |
|
| 06/02/2023 |
4
| Abdun-Nabi Daniel (Director) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Exercised 297 restricted stock units
@ $0
Granted 3,571 restricted stock units
@ $0 |
|
| 03/07/2023 |
4/A
| Abdun-Nabi Daniel (Director) has filed a Form 4 on Aptevo Therapeutics Inc. |
| 08/10/2022 |
4
| Abdun-Nabi Daniel (Director) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Granted 3,571 restricted stock units
@ $0 |
|
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2021 |
4
| Abdun-Nabi Daniel (Director) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Granted 10,000 options to buy
@ $35.52, valued at
$355.2k
|
|
| 06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/29/2020 |
4
| Abdun-Nabi Daniel (Director) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Disposed/sold 1,339 options to buy
@ $0
Disposed/sold 892 options to buy
@ $0
Disposed/sold 1,785 options to buy
@ $0
Granted 1,322 options to buy
@ $8.56, valued at
$11.3k
Granted 170 options to buy
@ $8.56, valued at
$1.5k
|
|
| 06/02/2020 |
4
| Abdun-Nabi Daniel (Director) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Granted 10,000 options to buy
@ $37.66, valued at
$376.6k
|
|
| 06/25/2019 |
4
| Abdun-Nabi Daniel (Board of Directors) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Bought 16,667 shares
@ $0.9, valued at
$15k
|
|
| 06/04/2019 |
4
| Abdun-Nabi Daniel (Director) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Granted 10,000 options to buy
@ $43.02, valued at
$430.2k
|
|
| 06/04/2019 |
4
| Abdun-Nabi Daniel (Board of Directors) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Granted 25,000 options to buy
@ $0.725, valued at
$18.1k
|
|
| 03/04/2019 |
4
| Abdun-Nabi Daniel (CEO) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Sold 14,565 shares
@ $58.107, valued at
$846.3k
|
|
| 02/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/18/2018 |
4
| Abdun-Nabi Daniel (CEO) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Sold 28,220 shares
@ $65, valued at
$1.8M
Sold 1,319 shares
@ $65, valued at
$85.7k
Exercised 28,220 options to buy
@ $13.38, valued at
$377.6k
Exercised 1,319 options to buy
@ $13.38, valued at
$17.6k
|
|
| 09/06/2018 |
4
| Abdun-Nabi Daniel (CEO) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Sold 60,000 shares
@ $60.5381, valued at
$3.6M
Sold 30,776 shares
@ $59.4926, valued at
$1.8M
Exercised 60,000 options to buy
@ $13.38, valued at
$802.8k
|
|
| 06/07/2018 |
4
| Abdun-Nabi Daniel (CEO) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Sold 15,785 shares
@ $52.1137, valued at
$822.6k
|
|
| 06/04/2018 |
4
| Abdun-Nabi Daniel (Director) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Granted 25,000 options to buy
@ $5.49, valued at
$137.3k
|
|
| 05/30/2018 |
4
| Abdun-Nabi Daniel (Director) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Granted 12,500 options to buy
@ $49.45, valued at
$618.1k
|
|
| 03/13/2018 |
4
| Abdun-Nabi Daniel (President & CEO) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Paid exercise price by delivering 7,825 shares
@ $51.84, valued at
$405.6k
|
|
| 03/01/2018 |
4
| Abdun-Nabi Daniel (President & CEO) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Granted 13,371 shares
@ $0
Paid exercise price by delivering 3,324 shares
@ $49.64, valued at
$165k
Paid exercise price by delivering 6,599 shares
@ $49.97, valued at
$329.8k
Granted 53,485 options to buy
@ $49.64, valued at
$2.7M
|
|
| 01/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/14/2017 |
4
| Abdun-Nabi Daniel (President & CEO) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Sold 20,000 shares
@ $45.99, valued at
$919.8k
Exercised 20,000 options to buy
@ $14.44, valued at
$288.8k
|
|
| 11/07/2017 |
4
| Abdun-Nabi Daniel (President & CEO) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Sold 11,508 shares
@ $42.5, valued at
$489.1k
Sold 20,000 shares
@ $42.92, valued at
$858.4k
Exercised 11,508 options to buy
@ $22.03, valued at
$253.5k
Exercised 20,000 options to buy
@ $14.44, valued at
$288.8k
|
|
| 09/29/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2017 |
4
| Abdun-Nabi Daniel (Director) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Granted 12,500 options to buy
@ $2.15, valued at
$26.9k
|
|
| 05/26/2017 |
4
| Abdun-Nabi Daniel (Director) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Granted 12,500 options to buy
@ $18.85, valued at
$235.6k
|
|
| 03/10/2017 |
4
| Abdun-Nabi Daniel (President & CEO) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Paid exercise price by delivering 8,226 shares
@ $30.98, valued at
$254.8k
Paid exercise price by delivering 10,738 shares
@ $31.05, valued at
$333.4k
|
|
| 03/02/2017 |
4
| Abdun-Nabi Daniel (President & CEO) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Granted 19,588 shares
@ $0
Granted 19,589 shares
@ $0
Paid exercise price by delivering 6,184 shares
@ $30.63, valued at
$189.4k
Granted 78,329 options to buy
@ $30.63, valued at
$2.4M
|
|
| 03/01/2017 |
4
| Abdun-Nabi Daniel (President & CEO) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Exercised 3,662 shares
@ $30.63, valued at
$112.2k
Paid exercise price by delivering 1,735 shares
@ $30.63, valued at
$53.1k
Paid exercise price by delivering 984 shares
@ $30.63, valued at
$30.1k
Exercised 3,662 options to buy
@ $14.51, valued at
$53.1k
|
|
| 01/12/2017 |
4
| Abdun-Nabi Daniel (President and CEO) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Acquired 1,979 shares
@ $0
Acquired 3,032 shares
@ $0
Acquired 3,419 shares
@ $0
Sold 28,240 shares
@ $31.2782, valued at
$883.3k
Acquired 3,662 options to buy
@ $14.51, valued at
$53.1k
Exercised 38,006 options to buy
@ $14.51, valued at
$551.5k
|
|
| 08/09/2016 |
4
| Abdun-Nabi Daniel (Director) has filed a Form 4 on REGENXBIO Inc. |
|